According to Consumer Reports, "Those taking sleeping pills have high risks and limited benefits. Taking Sleeping Pills for longer thatn 2 weeks can breed dependence." Have you tried to Stop Zopiclone only to suffer horrible insomnia that drove you to reinstate the Zopiclone? Are you looking for help Tapering Off Zopiclone but need to promote sleep throughout the Zopiclone Withdrawal? Our nonprofit has spent the last 15 years helping people escape Zopiclone dependency because we've been through it and made it our mission to help others recover. We take a powerful, holistic approach to helping to support Zopiclone Withdrawal and easing the nervous system while promoting sleep throughout the Zopiclone Taper. You can Get Off Zopiclone and sleep naturally again. You can recover and become free of Zopiclone dependency and you can do this while Tapering Off Zopiclone slowly, Weaning Off Zopiclone while your body continues to heal. Its a gentle way to help control Zopiclone Withdrawal and we have proven results. CONTACT our Zopiclone Experts for a Free Consultation.*
Our Zopiclone weaning program is a slow taper that allows you to safely step down from Zopiclone under the guidance of Our Team, Your Physician and Pharmacist. The Pre-Taper is for Symptom Relief. You will not wean Zopiclone until you feel better. This is where our Advanced Nutraceuticals are critical. Point of Return provides healthy, Drug-Free Strategies to help ease Zopiclone withdrawal and support well-being*
Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis. Our In-Home programs are individualized based on your situation. An assessment is done once you start the Zopiclone Withdrawal Program which allows us to individualize your gameplan based on age; length of time on the medications; health challenges; lifestyle, stress levels; additional medications; and interactions. Don't Wean Zopiclone alone, work with our Prescription Drug Experts.
Imagine being Free of Zopiclone Dependency
- Proven Withdrawal Program completed In-Home with Expert Guidance
- Slowly Wean off Zopiclone
- All-Natural Nutraceuticals to Help Ease Zopiclone Withdrawal
- Professional Information on Interactions
- Free Mentoring on our 24/7 Private Discussion Board
- Free Assessment Upon Starting our Program (a $400 value)
ZOPICLONE WITHDRAWAL SUCCESS STORIES
"If you are suffering terribly and can't see the way out, I am here now to tell you please do NOT loose heart - there IS hope. You WILL make it." More...
Carolyn (Zopiclone Withdrawal Success Story)
"I tapered successfully off of Zolpidem and today I am entirely drug-free and I fall asleep every night!" More...
Bianca (Zolpidem Withdrawal Success Story)
"I am now drug free! I sleep better than ever, and I am back as good as new, with a few extra miles." More...
Alex (Zolpidem Withdrawal Success Story)
"I simply cannot recommend Point of Return highly enough for people whose bodies have become dependent on medication(s). They know, they understand and they are there to help you." More...
Joel (Zolpidem Withdrawal Success Story)
"Thank you Point of Return for your never ending words of encouragement, advice, love and new found friendship. I am forever grateful to all of you." More...
Becky (Zolpidem Withdrawal Success Story)
"By utilizing the experienced, capable, and highly informed assistance available through Point of Return I have enabled my body, mind and spirit to recuperate. Point of Return's effective nutritional products alongside their unsurpassed support have given me a second chance." More...
Trudee (Zopiclone Withdrawal Success Story)
I am Zopiclone free and sleeping great. I know, without a doubt, that had I not found Point of Return, I would still be struggling and desperate. Thank you! You gave me my life back and I will be forever grateful to you. More...
—RIta (Zopiclone Withdrawal Success Story)
EXPERIENCE and TEAMWORK
using a Natural Approach
Zopiclone Frequently Asked Questions & Resource Center
People are much more successful tapering off Zopiclone when their withdrawal is customized, overseen and assisted by an experienced medical professional. An at-home Zopiclone withdrawal program such as the one provided by Point of Return can help you while tapering off Zopiclone. Read more.
Q: What is Zopiclone?
Zopiclone is a nonbenzodiazepine hypnotic agent used in the treatment of insomnia and is recommended for short-term use only (7 consecutive days). Read more.Q: What are the side effects of taking Zopiclone?
Zopiclone side effects include drowsiness, dizziness, lightheadedness, difficulty with coordination, memory loss or amnesia, tolerance, dependence, and changes in behavior and thinking. Read more.Q: Is Zopiclone Addictive?
Yes, Zopiclone is highly addictive and should only be used short term. Read more.
Q: What are Zopiclone Withdrawal Symptoms?
Zopiclone Withdrawal Symptoms include severe insomnia, abdominal pains, aching, agoraphobia, anxiety, blurred vision, body vibrations, changes in perception, diarrhea, distended abdomen, feeling of unreality, flu-like symptoms. Read more.Q: What are the proper rates for tapering off Zopiclone?
Zopiclone should be tapered slowly although the taper rates may vary depending on the length of time on Zopiclone, Age, other Medications, etc. Taper rates should be assessed properly. Read more.
ZOPICLONE HISTORY AND INFO ( link | pdf )
ZOPICLONE WITHDRAWAL HELP ( link )
Zopiclone History and Information
Zopiclone is a nonbenzodiazepine hypnotic agent used in the treatment of insomnia and is recommended for short-term use only (7 consecutive days). Z drugs were initially thought to be less addictive but time has shown a high
risk of dependence and withdrawal symptoms. Initially Zopiclone was marketed as a safer alternative to benzodiazepines but a meta analysis (quantitative statistical analysis) found there are few clear and consistent differences
between Zopiclone and benzodiazepines in terms of sleep onset, sleep duration, number of awakenings, quality of sleep, adverse events, tolerance, rebound insomnia and daytime alertness. More common reactions to Zopiclone
show a reduction in total time spent in REM sleep.
Zopiclone has shown it may have a greater addictive potential than Benzodiazepines and has been described as a "benzodiazepine in disguise". Tolerance to the effects of Zopiclone can develop after a few weeks and abrupt withdrawal
(particularly after prolonged use) can cause seizures and delirium. Due to the high dependence risk and effect on the GABA receptor, a gradual taper is recommended.
Zopiclone can cause horrible withdrawal symptoms that include a worsening of sleep and anxiety. It is critical to stop this drug properly and that is why our nonprofit was formed nearly 12 years ago. We know the importance of a slow-taper to allow the GABA receptors time to readjust at each reduction, but more importantly is getting the GABA receptors back to a healthy state so true sleep returns. Our program addresses each component of Zopiclone withdrawal - correct taper rates; all-natural items to ease symptoms; removing any interaction items through vitamins, over-the-counter, herbs, etc that actually increase symptoms and augmenting true healing.
It was introduced on the world market in 1988 but is not available in the United States, although its active molecular formula, Eszopiclone, is sold under the name Lunesta. Zopiclone is a controlled substance in the United States, Japan, Brazil, and some European countries. Sepracor Pharmaceutical separated the active compound of Zopiclone and patented it as Lunesta.
Zopiclone has shown it may have a greater addictive potential than Benzodiazepines and has been described as a "benzodiazepine in disguise". Tolerance to the effects of Zopiclone can develop after a few weeks and abrupt withdrawal (particularly after prolonged use) can cause seizures and delirium.
Zopiclone was first developed by Sepracor and introduced in 1986 by Rhone-Poulenc S.A., now part of Sanofi-Aventis who is the main manufacturer. On April 4, 2005 the United States Drug Enforcement Agency listed Zopiclone under Schedule IV, due to the evidence that the drug has addictive properties similar to benzodiazepines.
Zopiclone is not recommended during pregnancy as it is secreted in human milk and its concentrations may reach 50% of the plasma levels. Zopiclone is not recommended to nursing mothers.
#zopiclone-withdrawal-symptoms Zopiclone is cross-tolerant to Benzodiazepines and Alcohol, meaning that once tolerance to Zopiclone develops, the patient will also have tolerance to any Benzodiazepine and Alcohol. This places recovering alcoholics or benzodiazepine dependent individuals at a higher risk for dependency to Zopiclone.Zopiclone is not recommended during pregnancy as it is secreted in human milk and its concentrations may reach 50% of the plasma levels. Zopiclone is not recommended to nursing mothers.
Zopiclone Withdrawal Symptoms, Side Effects, Adverse Reactions
ZOPICLONE WITHDRAWAL SYMPTOMS MAY INCLUDE:
abdominal pains, aching, agoraphobia, anxiety, blurred vision, body vibrations, changes in perception, diarrhea, distended abdomen, feeling of unreality, flu-like symptoms, flatulence, food cravings, hair loss, heart palpitations, heavy limbs, increased allergies, increased sense of smell, insomnia, lethargy, loss of balance, metallic taste, muscle spasms, nightmares, panic attacks, paranoia, persistent & unpleasant memories, severe headaches, shaking, short term memory loss, sore mouth and tongue, sound & light sensitivity, speech difficulties, sweating, suicidal thoughts, tinnitus, unusually sensitive, fear
abdominal & muscle cramps, vomiting, sweating, shakiness, & rarely, seizures may occur & finally rebound insomnia
ZOPICLONE SIDE EFFECTS MAY INCLUDE:
drowsiness, dizziness, lightheadedness, difficulty with coordination, memory loss or amnesia, tolerance, dependence, changes in behavior and thinking; such as more outgoing or aggressive behavior than normal, confusion, strange behavior, agitation, hallucinations, worsening of depression, suicidal thoughts
ZOPICLONE ADVERSE REACTIONS MAY INCLUDE: per PDR
Severe: bronchospasm, oliguria, erythema multiforme, peptic ulce, suicidal ideation, angioedem, anaphylactoid reactions
Moderate: depression, confusion, hallucinations, memory impairment, myasthenia, oral ulceration, urinary incontinence, ataxia, vaginitis, melena, hypertonia, conjunctivitis, dysuria, cholelithiasis, hematuria, hypertension, lymphadenopathy, nystagmus, stomatitis, heat intolerance, anemia, hostility, cystitis, contact dermatitis, hypercholesterolemia, vaginal bleeding, peripheral neuropathy, euphoria, gastritis, hyperlipidemia, hypokalemia, myopathy, hepatomegaly, neuritis, photophobia, colitis, hepatitis, hyperesthesia, iritis, dehydration, phlebitis, hyperacusis, gout, dysphagia, furunculosis, migraine, chest pain (unspecified), peripheral edema, impaired cognition, dyspnea, complex sleep-related behaviors
Mild: dysgeusia, headache, drowsiness, infection, dizziness, xerostomia, dyspepsia, restlessness, nausea, diarrhea, rash, anxiety, abnormal dreams, vomiting, gynecomastia, dysmenorrhea, libido decrease, increased urinary frequency, fever, laryngitis, insomnia, xerophthalmia, hiccups, amenorrhea, tinnitus, xerosis, epistaxis, vertigo, anorexia, otalgia, skin discoloration, diaphoresis, malaise, weight loss, urticaria, halitosis, acne vulgaris, emotional lability, breast enlargement , muscle cramps, appetite stimulation, alopecia, photosensitivity, weight gain, paresthesias, polydipsia, agitation, menorrhagia, hirsutism, mydriasis, ptosis, tremor, maculopapular rash, dysosmia, somnambulism
ZOPICLONE BOXED WARNINGS: per PDR
Behavioral changes, CNS depression, coadministration with other CNS depressants, complex sleep-related behaviors, driving or operating machinery, drug-induced complex sleep-related behaviors, ethanol ingestion
Sedative-hypnotics can cause complex sleep-related behaviors such as phone calls, sexual activity, preparing and eating food, or sleep driving while not fully awake and in some cases having no memory of the event. These behaviors appear to be more frequent with nonbenzodiazepine benzodiazepine-receptor agonists (NBRAs), such as eszopiclone, than other sedative-hypnotics. Although rare, serious injuries or death have occurred; therefore, eszopiclone and other NBRAs are contraindicated in patients with a history of drug-induced complex sleep-related behaviors. Patients should be informed of the risks before receiving any medication from this class, including instructions to discontinue the medication if they experience a sleep-related episode and to contact their healthcare provider immediately. Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of NBRAs to the FDA MedWatch Safety Information and Adverse Event Reporting Program. Because eszopiclone has a rapid onset of action and causes CNS depression, it should only be administered before retiring. Patients should be instructed to avoid driving or operating machinery or performing other tasks requiring mental alertness after taking eszopiclone. Because eszopiclone can cause drowsiness and a decreased level of consciousness, there is a higher risk of falls, particularly in the elderly, with the potential for subsequent severe injuries. A variety of abnormal thinking and behavioral changes have been reported to occur in association with the use of sedative/hypnotics. Some of these changes may be characterized by decreased inhibition (e.g., aggressiveness and extroversion that seem out of character), similar to effects produced by alcohol and other CNS depressants. Other reported behavioral changes have included bizarre behavior, agitation, hallucinations, and depersonalization. Amnesia and other neuropsychiatric symptoms may occur unpredictably. Any emergence of changes in thinking or behavior should be evaluated. Although such behaviors may occur with the use of the drug alone at therapeutic doses, the use of higher doses, or the use of the drug with alcohol or the coadministration with other CNS depressants appears to increase the risks. Advise patients to avoid ethanol ingestion. Eszopiclone can cause next-day psychomotor and memory impairment, with patients often unaware that they are impaired. Results from one study indicate that peak impairment after a 3 mg dose occurs 7.5 hours later, with clinically relevant effects still present at 11.5 hours after the dose. Lower initial dosages of eszopiclone should be considered in patients taking other CNS depressant therapies.
Zopiclone References and FDA Information
According to the FDA:
Following rapid dose decrease or abrupt discontinuation of the use of sedative/hypnotics, there have been reports of signs and symptoms similar to those associated with withdrawal from other CNS-depressant drugs [see Drug Abuse and Dependence (9)].
Withdrawal Effects: symptoms may occur with rapid dose reduction or discontinuation
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements/inso on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
* Testimonial results may vary person to person.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized With Your physician to help you with your drug withdrawal process and with his or her consent and support throughout.
*This program is not meant to cure or prevent any disease or illness.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support throughout the process. More..